TRDA
Entrada TherapeuticsBNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
Operating peers and competitors
Source-backed product markets and frozen research comparisons. Valuation comparators remain in the existing peer table.
Loading market evidence...
Research comparisons do not establish forecast usefulness or trading returns.
Compare shared product markets
Membership only; no portfolio weights or estimated losses.
+
Peers tracked
10
U.S. public peers
Grade Position
Above peers
vs peer average
TRDA vs peer average
90/100
TRDA vs. peer average (B vs. D)
Grade spread
C 2 · D 1 · F 7
Graded peers loaded
Coverage
10 graded
100% of tracked
Peer overview
DYN is the first available peer comparator.
Dyne is a direct clinical DMD exon-skipping comparator, but its program maturity makes it an imperfect valuation peer [Dyne SEC exhibit](https://www.sec.gov/Archives/edgar/data/1818794/000119312525310516/d16518dex991.htm).
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
TRDA
Entrada Therapeutics
DYN
Dyne Therapeutics
Grade
B
F
Momentum
5
14
Value
59
41
Sentiment
72
3
Setup Bias
Net —
-
Market Cap
-
-
Posture
Constructive
Defensive
Grade position vs DYN
TRDA / DYN
Grade Position
Above peers
TRDA vs. peer average (B vs. D)
90/100
Momentum
5
DYNValue
59
TRDASentiment
72
TRDARotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs TRDA
DYN is the first peer returned for this comparison set.